Tamiflu (Oseltamivir Phosphate) Market, by Drug Type (Branded and Generic), by Dosage Form (Capsules and Suspension), by Indication (Influenza A, Influenza B, and Swine Flu (H1N1 Influenza A)), by Distribution Channel (Hospital Pharmacies, Retail Pharmaci

Tamiflu (Oseltamivir Phosphate) Market, by Drug Type (Branded and Generic), by Dosage Form (Capsules and Suspension), by Indication (Influenza A, Influenza B, and Swine Flu (H1N1 Influenza A)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Oseltamivir phosphate is indicated for the treatment of influenza A, influenza B, and Others. It reduces the symptoms caused by influenza virus such as stuffy nose, cough, sore throat, fever/chills, aches, and tiredness. Moreover, the medicine reduces the recovery time by 1-2 days. This medication may also be used to prevent the flu if the person is exposed to other patient who already is suffering from flu or if there is a flu pandemic in the community. The mode of action for the treatment is that, this medication works by stopping the flu virus from growing. The medicine should be taken at the proper time interval as prescribed by the doctor. If the intake of medicine is terminated at an early stage then, this may lead to the growth of the virus, which may relapse of the infection.

Market Dynamics

Increasing incidence of influenza among the U.S. population is expected to increase the growth of the global Tamiflu (oseltamivir phosphate) market over the forecast period. For instance, according to the article published in the Lancet journal, 2022, the annual incidence of symptomatic influenza is estimated to vary from 3 to 11%. According to the various studies carried out by the researchers in National Center for Immunization and Respiratory Diseases, U.S., it was found that, influenza virus infections and illness rates are highest in children and the rate of illness decrease with the increasing age.

Increasing launches of Tamiflu (oseltamivir phosphate) is expected to drive the growth of the global Tamiflu (oseltamivir phosphate) over the forecast period. For instance, in 2018, Natco Pharma, Indian pharmaceutical company and their marketing partner Alvogen, U.S. based pharmaceutical company launched, the first generic version of Tamiflu (oseltamivir phosphate) in the U.S.

Key features of the study:

  • This report provides in-depth analysis of the global Tamiflu (oseltamivir phosphate) market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global Tamiflu (oseltamivir phosphate) market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include F.Hoffmann-La Roche Ltd., NATCO Pharma Limited, Tea Pharmaceutical Industries Ltd., LUPIN Limited, Amneal Pharmaceuticals LLC, Zydus Cadila, Sun Pharmaceutical Industries Ltd., Alembic Pharmaceuticals Limited, Mylan N.V., and Hetero Group.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global Tamiflu (oseltamivir phosphate) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Tamiflu (oseltamivir phosphate) market
Detailed Segmentation:
  • Global Tamiflu (Oseltamivir Phosphate) Market, By Drug Type:
  • Branded
  • Generic
  • Global Tamiflu (Oseltamivir Phosphate) Market, By Dosage Form:
  • Capsules
  • Suspension
  • Global Tamiflu (Oseltamivir Phosphate) Market By Indication:
  • Influenza A
  • Influenza B
  • Swine Flu (H1N1 Influenza A)
  • Global Tamiflu (Oseltamivir Phosphate) Market By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Tamiflu (Oseltamivir Phosphate) Market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • F. Hoffmann-La Roche Ltd.*
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • NATCO Pharma Limited
  • Teva Pharmaceutical Industries Ltd.
  • LUPIN Limited
  • Amneal Pharmaceuticals LLC
  • Zydus Cadila
  • Sun Pharmaceutical Industries Ltd.
  • Alembic Pharmaceuticals Limited
  • Mylan N.V.
  • Hetero Group
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Drug Type
Market Snapshot, By Dosage Form
Market Snapshot, By Indication
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Attractiveness Analysis
Market Opportunities
Product Launches
Market Trends
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Technology Landscape
Pricing Analysis (2021)
4. Global Tamiflu (Oseltamivir Phosphate) Market – Impact of Coronavirus (Covid-19) Pandemic
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Tamiflu (Oseltamivir Phosphate) Market, By Drug Type, 2017 – 2030, (US$ Million)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Branded
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Generic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
6. Global Tamiflu (Oseltamivir Phosphate) Market, By Dosage Form, 2017 – 2030, (US$ Million)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Capsules
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Suspension
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
7. Global Tamiflu (Oseltamivir Phosphate) Market, By Indication, 2017 – 2030, (US$ Million
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segments Trends
Influenza A
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Influenza B
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Swine Flu (H1N1 Influenza A)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
8. Global Tamiflu (Oseltamivir Phosphate) Market, By Distribution Channel, 2017 – 2030, (US$ Million)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segments Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
9. Global Tamiflu (Oseltamivir Phosphate) Market, By Region, 2017 – 2030, (US$ Million)
Introduction
Market Share Analysis, By Region, 2022 and 2030 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2030
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Million)
North Africa
Central Africa
South Africa
10. Competitive Landscape
F.Hoffmann-La Roche Ltd.*
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
NATCO Pharma Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
LUPIN Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Amneal Pharmaceuticals LLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Zydus Cadila
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Sun Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Alembic Pharmaceuticals Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Mylan N.V
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
HeterGroup
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
11. Section
Research Methodology
About Us
*Browse 29 market data tables and 22 figures on “Global Tamiflu (Oseltamivir Phosphate) Market” - Global forecast t2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings